163 related articles for article (PubMed ID: 36680967)
1. Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study.
Hassanein M; Malek R; Shaltout I; Sahay RK; Buyukbese MA; Djaballah K; Pilorget V; Coudert M; Al Sifri S;
Diabetes Metab Syndr; 2023 Feb; 17(2):102707. PubMed ID: 36680967
[TBL] [Abstract][Full Text] [Related]
2. Safety and effectiveness of iGlarLixi in adults with type 2 diabetes mellitus from Gulf countries during Ramadan holy month: A subgroup analysis of the SoliRam observational study.
Hassanein M; El Naggar A; Al Sheikh A; Djaballah K; Saeed M; Melas-Melt L; AlSifri S
Diabetes Res Clin Pract; 2024 Mar; 209():111567. PubMed ID: 38341039
[TBL] [Abstract][Full Text] [Related]
3. Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study.
Hassanein M; Buyukbese MA; Malek R; Pilorget V; Naqvi M; Berthou B; Shaltout I; Kumar Sahay R
Diabetes Res Clin Pract; 2020 Aug; 166():108189. PubMed ID: 32360709
[TBL] [Abstract][Full Text] [Related]
4. Real-world Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Mellitus During the Period of Ramadan in Four Countries (Egypt, Jordan, Lebanon, and Turkey): A Prospective Observational Study.
Hassanein M; Shaltout I; Malek R; Assaad Khalil S; Ballout H; Annabi F; Shereen M
Curr Diabetes Rev; 2024; 20(5):e110823219694. PubMed ID: 37581325
[TBL] [Abstract][Full Text] [Related]
5. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes.
Afandi B; Kaplan W; Al Hassani N; Hadi S; Mohamed A
J Endocrinol Invest; 2017 Jul; 40(7):741-744. PubMed ID: 28239763
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.
Hassanein M; Abdallah K; Schweizer A
Vasc Health Risk Manag; 2014; 10():319-26. PubMed ID: 24920915
[TBL] [Abstract][Full Text] [Related]
7. Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus.
Ibrahim M; Barker MM; Ahmad E; Ahmed A; Annabi FA; Ba-Essa EM; Davies MJ; Houeiss P; Iraqi H; Masood SN; Mimouni-Zerguini S; Shaikh S; Tantawi H; Tuomilehto J
Diabetes Metab Res Rev; 2023 Mar; 39(3):e3604. PubMed ID: 36547366
[TBL] [Abstract][Full Text] [Related]
8. Attitude and safety of patients with diabetes observing the Ramadan fast.
Ba-Essa EM; Hassanein M; Abdulrhman S; Alkhalifa M; Alsafar Z
Diabetes Res Clin Pract; 2019 Jun; 152():177-182. PubMed ID: 30946851
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety benefits of iGlarLixi versus insulin glargine 100 U/mL or lixisenatide in Asian Pacific people with suboptimally controlled type 2 diabetes on oral agents: The LixiLan-O-AP randomized controlled trial.
Yang W; Dong X; Li Q; Cheng Z; Yuan G; Liu M; Xiao J; Gu S; Niemoeller E; Chen L; Ping L; Souhami E;
Diabetes Obes Metab; 2022 Aug; 24(8):1522-1533. PubMed ID: 35441412
[TBL] [Abstract][Full Text] [Related]
10. Real-world evidence on the use of a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) in people with suboptimally controlled type 2 diabetes in Romania: a prospective cohort study (STAR.Ro).
Bala C; Cerghizan A; Mihai BM; Moise M; Guja C
BMJ Open; 2022 May; 12(5):e060852. PubMed ID: 35623748
[TBL] [Abstract][Full Text] [Related]
11. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694
[TBL] [Abstract][Full Text] [Related]
12. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.
Aravind SR; Ismail SB; Balamurugan R; Gupta JB; Wadhwa T; Loh SM; Suryawanshi S; Davies MJ; Girman CJ; Katzeff HL; Radican L; Engel SS; Wolthers T
Curr Med Res Opin; 2012 Aug; 28(8):1289-96. PubMed ID: 22738801
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of empagliflozin in people with type 2 diabetes during Ramadan fasting.
Yousuf S; Ahmedani MY
Diabetes Metab Syndr; 2022 Nov; 16(11):102633. PubMed ID: 36279701
[TBL] [Abstract][Full Text] [Related]
14. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study.
Khalil AB; Beshyah SA; Abu Awad SM; Benbarka MM; Haddad M; Al-Hassan D; Kahwatih M; Nagelkerke N
Diabetes Technol Ther; 2012 Sep; 14(9):813-8. PubMed ID: 22827507
[TBL] [Abstract][Full Text] [Related]
15. Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2i) during the month of Ramadan in patients with type 2 diabetes mellitus in Pakistani population-an observational study from a tertiary care center in Karachi.
Sheikh A; Das B; Sattar S; Islam N
Endocrine; 2023 Apr; 80(1):64-70. PubMed ID: 36580199
[TBL] [Abstract][Full Text] [Related]
16. Effect of fasting ramadan in diabetes control status - application of extensive diabetes education, serum creatinine with HbA1c statistical ANOVA and regression models to prevent hypoglycemia.
Aziz KM
Recent Pat Endocr Metab Immune Drug Discov; 2013 Sep; 7(3):233-51. PubMed ID: 23964680
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan.
Salti I;
Diabet Med; 2009 Dec; 26(12):1255-61. PubMed ID: 20002478
[TBL] [Abstract][Full Text] [Related]
18. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus.
Alawadi F; Alsaeed M; Bachet F; Bashier A; Abdulla K; Abuelkheir S; Rashid F; Abdulaziz Bin Hussain A; Abdelgadir E; Alsayyah F; Elsayed M; Hassanein M
Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155
[TBL] [Abstract][Full Text] [Related]
19. Positive impact of pre-Ramadan education on glycemic control and reducing risk of hypoglycemia in type 2 diabetic elderly patients during COVID 19 pandemic.
El Toony LF; Elghazally SA; Hamad DA
Prim Care Diabetes; 2022 Aug; 16(4):581-587. PubMed ID: 35491316
[TBL] [Abstract][Full Text] [Related]
20. Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study.
Uddin MF; Khan MA; Selim S; Sultana N; Sayem MA; Iftekhar MM; Habib MB; Akter N; Khan S
J Comp Eff Res; 2024 Feb; 13(2):e230132. PubMed ID: 38294337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
